Navigation Links
Honda to Showcase Experimental Walking Assist Device
Date:4/22/2008

TOKYO, April 22 /PRNewswire/ -- Honda Motor Co., Ltd. will showcase an experimental model of a walking assist device which could support walking for the elderly and other people with weakened leg muscles, at the International Trade Fair on Barrier Free Equipments & Rehabilitation for the Elderly & the Disabled (BARRIER FREE 2008) which will be held at Intex Osaka, Friday, April 25 through Sunday, April 27, 2008.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080422/LATU095A)

Designed for people who are still capable of walking on their own, Honda began research of a walking assist device in 1999 with a goal to provide more people with the joy of mobility. Currently, the device has entered into the feasibility stage.

The cooperative control technology utilized for this device is a unique Honda innovation achieved through the cumulative study of human walking just as the research and development of technologies was conducted for Honda's advanced humanoid robot, ASIMO. Applying cooperative control based on the information obtained from hip angle sensors, the motors provide optimal assistance based on a command from the control CPU. With this assist, the user's stride will be lengthened compared to the user's normal stride without the device and therefore the ease of walking is achieved.

The compact design of the device was achieved with flat brushless motors and a control system developed by Honda. In addition, a simple design to be worn with a belt around the hip and thigh was employed to help achieve overall weight as light as approximately 2.8kg. As a result, the device reduces the user's load and can be fit to different body shapes.

The research of this device is being conducted by the Fundamental Technology Research Center of Honda R&D Co., Ltd. in Wako, Saitama, Japan.

Key specifications of the experimental walking assist device

Size 3 sizes (Small, Medium, Large)

Distance between motors

(S)312mm,(M)342mm,(L)372mm

Weight (kg) 2.8 (Medium size)

Drive system (motor/reduction ratio) Brushless DC motor/10

Battery (type/capacity) Lithium ion battery/22.2V-1Ah

Operating time per charge 2 hours (when operated at

4.5km/hour walking)

About Honda

Honda Motor Co., Ltd., the world's preeminent engine maker, producing more than 26 million engines annually for a diverse range of products including automobiles, motorcycles and power equipment products. Founded in Japan in 1948, Honda began operations in the U.S. in 1959 with the establishment of American Honda Motor Co., Inc. (http://www.honda.com), Honda's first overseas subsidiary. Honda began U.S. production of motorcycles in 1979 and automobiles in 1982. Honda began making power equipment products in Swepsonville, North Carolina in 1984, producing engines and lawnmowers. The company has invested more than $10.6 billion in its North American operations, with employment of more than 35,000 associates, and annual purchases of more than $18 billion in parts and materials from suppliers in North America.

Online multimedia newsroom available at: http://www.hondanews.com


'/>"/>
SOURCE Honda Motor Co., Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. CBaySystems to Give Away a 2008 Honda Civic at AHIMA 2007
2. CBaySystems Gives Away 2008 Honda Civic at AHIMA 2007
3. Mothers Know Best: NFL Moms Team With Eddie George to Showcase a Better Way to a Healthier Lifestyle
4. Fresh Air Campaign to Showcase Minnesotans Love of Smoke-Free Air
5. Health Integrated to Showcase Synergy Personal Health Management(R) at DMAA Conference
6. SNM seeks novel approaches to molecular imaging to showcase at annual meeting
7. SNM seeks novel approaches to molecular imaging to showcase at annual meeting
8. Peer-Reviewed, Online Database Showcases Local, County and State Pandemic Planning
9. Global Latex Conference to Showcase Vytex(TM) NRL
10. The era of global aging: GSA showcases cutting-edge San Francisco meeting topics
11. China Shenghuo Pharmaceutical Holdings, Inc. Opens Showcase 12Ways(R) Chinese Herbal Beauty Salon in October
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... ... 27, 2016 , ... More than a third of American adults are considered ... surgery has received increased attention in recent years, as an article published ... weight loss, most people are familiar with the basic requirements of maintaining a healthy ...
(Date:5/27/2016)... ... ... With over 60 percent of acute stroke survivors being left unable to ... in the rehabilitation process has steadily increased. Ekso Bionics had been working to help ... stroke. , Ekso Bionics has now received clearance from the U.S. Food and Drug ...
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed ... by inspiring human interest stories, courtesy of leaders in the nursing and health ... the industry, from leading advocates and associations—namely Jones & Bartlett Learning. , Jones ...
(Date:5/26/2016)... ... ... There are many ways to cook a hot dog, but new research commissioned ... dogs straight off the grill. Of the 90 percent of Americans who say they ... hot dog, far outpacing other cooking methods such as steaming (12 percent), microwaving (9 ...
(Date:5/26/2016)... , ... May 26, 2016 , ... Connor Sports, ... basketball as a partner for the Tamika Catchings Legacy Tour that will ... industry leader in hardwood basketball surfaces in all forms and levels of the game, ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... MedDay, a biotechnology company focused on the treatment ... "High doses of biotin in progressive multiple sclerosis: extension phase ... Ayman Tourbah , Principal Investigator of the Phase 3 ... Neurology (EAN) in Copenhagen, Denmark . The ... on Sunday, 29 May 2016 from 14:45 to 16:15 CEST ...
(Date:5/24/2016)... --   , ... Endpunkte und demonstriert Ebenbürtigkeit bei der Gesamtreinigung des ... guter , Reinigung des ... (Logo: http://photos.prnewswire.com/prnh/20130829/633895-a ) , ... der MORA-Studie der Phase III für NER1006 (1 ...
(Date:5/24/2016)... Celsion Corporation (NASDAQ: CLSN ... an update on its ongoing OVATION study, a ... the Company,s DNA-based immunotherapy, with the standard of ... advanced ovarian cancer who will undergo neoadjuvant chemotherapy ... IL-12 DNA plasmid vector formulated as a nanoparticle ...
Breaking Medicine Technology: